Back to Trades
WENTWORTH KORY JAMES
Chief Financial OfficerCIK 0001725663
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
WENTWORTH KORY JAMES, Chief Financial Officer, accounts for 3 disclosed filings worth $1.0M, all concentrated in Entrada Therapeutics, Inc. (TRDA), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $97.9K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Mar 6 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $97.9K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Grant | $896.0K |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Tax withheld | $9.4K |
3 filings